CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
NEUROLITHdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03770182
NCT03770182N/ACompleted
CompareCT.gov

Brain Stimulation for Neurological Patients

Storz Medical AG·interventional·Posted Dec 10, 2018·Updated Nov 22, 2023

In Brief

A clinical study evaluating NEUROLITH for Alzheimer Disease. Completed, enrolled 60 participants across 1 site.

Detailed Summary

This is a prospective double-blind randomized placebo-controlled crossover clinical trial

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlzheimer Disease
CountriesAustria
CollaboratorsMedical University of Vienna

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedDec 10, 2018
Enrollment StartJan 1, 2017
Primary CompletionJul 27, 2022
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 7.6 years ago

Interventions

NEUROLITHdevice

transcranial pulse stimulation (TPS)